by Madaline Spencer | Oct 23, 2026
The US Food and Drug Administration (FDA) has approved Evoxac (cevimeline HCI) oral solution to address dry mouth in patients with Sjögren’s disease (SjD). SjD is an autoimmune disorder that largely impacts secretory glands. It is also associated with rheumatic...
by Madaline Spencer | Oct 22, 2026
The US Food and Drug Administration (FDA) has approved Enspryng (satralizumab) for the treatment of adults with thyroid eye disease (TED). TED is a chronic endocrine, autoimmune disease characterized by immune-mediated orbital inflammation that greatly...
by Madaline Spencer | Oct 20, 2026
Andrew Dauber, MD, MMsc, Chief of Endocrinology at Children’s National, discusses the efficacy of vosoritide to treat persons with hypochondroplasia. Hypochondroplasia is a rare skeletal disease characterized by very short stature, similar to...
by Madaline Spencer | Oct 19, 2026
Daniela Rogoff, MD, PhD, Chief Medical Officer, Skeletal Dysplasia of BridgeBio, discusses the efficacy of infigratinib to treat persons with achondroplasia. Achondroplasia is a disorder of bone growth that prevents the changing of cartilage to bone,...
by Madaline Spencer | Oct 16, 2026
Jane Salmon, MD, Professor of Medicine at Weill Cornell Medical College, discusses antiphospholipid syndrome (APS), its impact on pregnancy, and emerging research into Cimzia (certolizumab pegol) as a potential approach to preventing serious pregnancy complications. ...
